Minerva Advisors’s Kura Oncology KURA Stock Holding History

Minerva Advisors’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-26,215	Closed	-$856K	–	74
2020 Q4	$856K	Hold	26,215	–	–	0.47%	35
2020 Q3	$803K	Sell	26,215 -38,597	-60%	-$852K	0.54%	29
2020 Q2	$1.06M	Sell	64,812 -10,779	-14%	-$155K	0.71%	25
2020 Q1	$748K	Sell	75,591 -1,831	-2%	-$21K	0.59%	30
2019 Q4	$1.06M	Sell	77,422 -8,665	-10%	-$128K	0.57%	32
2019 Q3	$1.31M	Sell	86,087 -2,292	-3%	-$40.8K	0.73%	26
2019 Q2	$1.74M	Sell	88,379 -240	-0.3%	-$3.98K	0.94%	25
2019 Q1	$1.47M	Hold	88,619	–	–	0.83%	26
2018 Q4	$1.24M	Hold	88,619	–	–	0.8%	28
2018 Q3	$1.55M	Sell	88,619 -14,400	-14%	-$276K	0.79%	28
2018 Q2	$1.88M	Sell	103,019 -2	-0%	-$34	0.96%	26
2018 Q1	$1.93M	Sell	103,021 -67,900	-40%	-$1.32M	1.02%	26
2017 Q4	$2.61M	Sell	170,921 -57,300	-25%	-$844K	1.41%	22
2017 Q3	$3.4M	Sell	228,221 -61,500	-21%	-$577K	1.8%	16
2017 Q2	$2.68M	Sell	289,721 -7,400	-2%	-$67.4K	1.49%	19
2017 Q1	$2.6M	Sell	297,121 -25,100	-8%	-$184K	1.39%	19
2016 Q4	$1.87M	Hold	322,221	–	–	1.06%	26
2016 Q3	$2.01M	Sell	322,221 -39,516	-11%	-$200K	1.26%	22
2016 Q2	$977K	Buy	+361,737	New	+$1.13M	0.66%	36

Other funds holding KURA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

FCMI

Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Minerva Advisors's KURA Position: Q1 2021 in Review

Minerva Advisors sold out of Kura Oncology (KURA) in Q1 2021, closing a stake of 26,215 shares — an estimated $856K sold.

Minerva Advisors first reported a position in KURA in Q2 2016 and held it in 19 quarters. The position peaked at $3.4M in Q3 2017. 171 funds tracked by Wall St. Rank hold KURA as of Q1 2021.

Minerva Advisors reported no remaining Kura Oncology position as of Q1 2021 after selling out during the quarter.
Minerva Advisors sold 26,215 Kura Oncology shares in Q1 2021, an estimated $856K.
Minerva Advisors first reported a position in Kura Oncology in Q2 2016 and held it in 19 quarters.
Minerva Advisors's Kura Oncology position peaked at $3.4M in Q3 2017.
171 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2021.

Based on Minerva Advisors's 13F filing for Q1 2021, filed 12 May 2021.